{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:51:32Z","timestamp":1791215492738,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022720","name":"Health Bureau","doi-asserted-by":"publisher","award":["CID-HKU2"],"award-info":[{"award-number":["CID-HKU2"]}],"id":[{"id":"10.13039\/100022720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108848","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:36:10Z","timestamp":1780331770000},"page":"108848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SARS-CoV-2 viral shedding and vaccination\u2011modified effects of oral antivirals in older COVID-19 patients: A retrospective cohort study in Hong Kong"],"prefix":"10.1016","volume":"170","author":[{"given":"Yun","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-9401","authenticated-orcid":false,"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric H.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim K.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Fan Ngai","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108848_bib0001","article-title":"Comparison of control and transmission of COVID-19 across epidemic waves in Hong Kong: an observational study","volume":"43","author":"Yang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.ijid.2026.108848_bib0002","unstructured":"The Government of Hong Kong SAR. First shipment of COVID-19 oral drug Paxlovid distributed to HA for application (with photos). 2022. https:\/\/www.info.gov.hk\/gia\/general\/202203\/15\/P2022031500280.htm. [Accessed 25 May 2023]."},{"key":"10.1016\/j.ijid.2026.108848_bib0003","unstructured":"The Government of Hong Kong SAR. LCQ7: introduction of new drugs for treating coronavirus disease 2019. 2022 https:\/\/www.info.gov.hk\/gia\/general\/202202\/23\/P2022022300303.htm. [Accessed 25 May 25 2023]."},{"key":"10.1016\/j.ijid.2026.108848_bib0004","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S1473-3099(22)00507-2","article-title":"Real-world effectiveness of early molnupiravir or nirmatrelvir-ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong\u2019s omicron BA.2 wave: a retrospective cohort study","volume":"22","author":"Wong","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0005","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108848_bib0006","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1473-3099(23)00118-4","article-title":"Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system","volume":"23","author":"Lewnard","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0007","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.1038\/s41467-023-43706-0","article-title":"Optimal timing of nirmatrelvir\/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation","volume":"14","author":"Wong","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108848_bib0008","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for high-risk, nonhospitalized adults with covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108848_bib0009","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(23)00493-0","article-title":"Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial","volume":"24","author":"Schilling","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-3099(22)00644-2","article-title":"Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial","volume":"23","author":"Khoo","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0011","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/ph16050721","article-title":"Molnupiravir, nirmatrelvir\/ritonavir, or sotrovimab for high-risk COVID-19 patients infected by the Omicron variant: hospitalization, mortality, and time until negative swab test in real life","volume":"16","author":"Cegolon","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijid.2026.108848_bib0012","article-title":"Can nirmatrelvir\/ritonavir treatment shorten the duration of COVID-19 isolation?","volume":"9","author":"Kim","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijid.2026.108848_bib0013","article-title":"Understanding the viral shedding time of Omicron variant BA.2 infection in Shanghai: a population-based observational study","volume":"9","author":"Lu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.ijid.2026.108848_bib0014","article-title":"Factors associated with prolonged viral shedding in older patients infected with Omicron BA.2.2","volume":"10","author":"Zhong","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2026.108848_bib0015","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.3201\/eid2809.220613","article-title":"Epidemiology of infections with SARS-CoV-2 omicron BA.2 variant, Hong Kong, January-March 2022","volume":"28","author":"Mefsin","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(23)00146-5","article-title":"Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study","volume":"4","author":"Lin","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ijid.2026.108848_bib0017","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81849","article-title":"Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study","volume":"11","author":"Hay","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ijid.2026.108848_bib0018","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1764","article-title":"Viral cultures for coronavirus disease 2019 infectivity assessment: a systematic review","volume":"73","author":"Jefferson","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0019","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S1473-3099(24)00353-0","article-title":"Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and remdesivir versus monotherapy with remdesivir or nirmatrelvir-ritonavir in patients hospitalised with COVID-19: a target trial emulation study","volume":"24","author":"Choi","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0020","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac443","article-title":"Effectiveness of Paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients","volume":"76","author":"Najjar-Debbiny","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0021","article-title":"Short-term effectiveness of oral nirmatrelvir\/ritonavir against the SARS-CoV-2 omicron variant and culture-positive viral shedding","volume":"38","author":"Lee","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijid.2026.108848_bib0022","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/M22-3057","article-title":"Effectiveness of molnupiravir and nirmatrelvir-ritonavir in hospitalized patients with COVID-19: a target trial emulation study","volume":"176","author":"Wan","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2026.108848_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102225","article-title":"Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study","volume":"64","author":"Wan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2026.108848_bib0024","first-page":"547","article-title":"Efficacy and safety of oral antivirals in individuals aged 80 years or older with mild-to-moderate COVID-19: preliminary report from an Italian Prescriber Center","volume":"30","author":"Bruno","year":"2022","journal-title":"Infez Med"},{"key":"10.1016\/j.ijid.2026.108848_bib0025","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1038\/s41467-023-40556-8","article-title":"Comparing molnupiravir and nirmatrelvir\/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models","volume":"14","author":"Cox","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.108848_bib0026","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.vaccine.2023.03.070","article-title":"BBIBP-CorV vaccination accelerates anti-viral antibody responses in heterologous Omicron infection: a retrospective observation study in Shanghai","volume":"41","author":"Bao","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108848_bib0027","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.immuni.2021.04.023","article-title":"Vaccination reshapes the virus-specific T cell repertoire in unexposed adults","volume":"54","author":"Pan","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2026.108848_bib0028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cell.2022.12.018","article-title":"Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ijid.2026.108848_bib0029","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/infdis\/jiaa802","article-title":"Performance characteristics of a rapid severe acute Respiratory syndrome coronavirus 2 antigen detection assay at a public plaza testing site in San Francisco","volume":"223","author":"Pilarowski","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108848_bib0030","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001483","article-title":"Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020","volume":"25","author":"Singanayagam","year":"2020","journal-title":"Euro Surveill"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:00:23Z","timestamp":1791212423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226004832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S1201971226004832"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108848","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 viral shedding and vaccination\u2011modified effects of oral antivirals in older COVID-19 patients: A retrospective cohort study in Hong Kong","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108848","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108848"}}